Activities

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

The pathogenesis of type 1 diabetes (T1D) is now recognized to involve a progression of disease that advances through distinct stages prior to the onset of symptoms. With therapy now available to delay the onset of symptomatic T1D—and give the...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

C3 glomerulopathy (C3G) is a rare, complement-mediated kidney disease characterized by abnormal activation of the complement system, resulting in excessive deposition of the complement protein C3 in the glomeruli and subsequent inflammation and injury. To address unmet needs and education...

Adenosine deaminase–deficient severe combined immunodeficiency (ADA-SCID) is a rare, life-threatening inborn error of the immune system characterized by profound T-, B-, and NK-cell dysfunction and multiorgan complications beginning in early infancy. Integration of newborn screening using T-cell receptor excision circles,...

The BURST CME™ format is an online, on-demand video program designed to deliver concise, modular education. In these modules, Hanford Yau, MD, and Stephen J. Greene, MD, review the relationship between hypercortisolism and hypertension, identifying patients with resistant hypertension who...

This online activity is designed to update clinicians on data presented at the 25th EURETINA Congress that was held from September 4 to 7, 2025, in Paris, France; the 59th Annual Meeting of the Retina Society that was held on...

In the rapidly expanding oncology treatment landscape, multidisciplinary care is essential for managing any treatment-related adverse events. This program will provide eye care clinicians with the knowledge and competence to manage ocular toxicities associated with antibody-drug conjugates, monoclonal antibodies, and...

This online, on-demand virtual symposium brings together renowned retina specialists to discuss the treatment of macular telangiectasia (MacTel) type 2, which is a rare, progressive retinal disease. In this educational program, these experts discuss recent innovations in approved therapy for...

This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding the management of DED and share their perspectives and best...